Three things to know:
1. In 2015, Anthem extended an offer to acquire Cigna in a $48.9 billion cash and stock deal. However, the deal ended two years later due to antitrust concerns.
2. The insurers are now in court debating which one was responsible for the deal’s failure and potentially owes the other billions, according to Bloomberg Quint. While Cigna argues it’s owed $15 billion as the injured party, Anthem claims it’s owed $20 billion because Cigna sabotaged the deal.
2. A Delaware judge will start the 10-day trial Feb. 25, which will include testimony from Blue Cross Blue Shield Association CEO Scott Serota. Mr. Serota is expected to testify about Cigna’s accusation against Anthem that it did not try its best to address antitrust concerns, according to the report.
More articles on payers:
BCBS of Michigan accused of charging hidden fees
UnityPoint back in network with Humana, Molina
Anthem study: Employers are increasingly bundling health benefits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
